Oteba Martin, Wagner Anita Katharina, Seru Morries, Embrey Martha, Trap Birna
Management Sciences for Health, Plot 15, Princess Anne Drive, Bugolobi, P.O. Box 71419, Kampala, Uganda.
2Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215 USA.
J Pharm Policy Pract. 2018 Oct 15;11:23. doi: 10.1186/s40545-018-0150-1. eCollection 2018.
A strong pharmaceutical sector is a precondition for effective and efficient health care and financing systems, and thus for achieving the best possible health of a population. Supported by visionary, long-term donor funds, in conjunction with mutual trust, the USAID-funded Securing Ugandans Rights to Essential Medicines (SURE) and Uganda Health Supply Chain (UHSC) program engaged in a close, more than 10 year-long (in 2018) collaboration with the Ministry of Health of Uganda. Over time, the partnership implemented numerous multi-pronged comprehensive changes in the pharmaceutical sector and conducted research to document successes and failures. We describe the evolution and key characteristics of the SURE/UHSC interventions.
强大的制药部门是建立有效且高效的医疗保健和融资体系的前提条件,从而也是实现民众最佳健康状况的前提条件。在美国国际开发署(USAID)资助的保障乌干达民众基本药物权利(SURE)和乌干达卫生供应链(UHSC)项目中,在有远见的长期捐助资金支持下,加上相互信任,与乌干达卫生部开展了紧密的、长达十多年(截至2018年)的合作。随着时间推移,该伙伴关系在制药部门实施了众多多方面的全面变革,并开展研究以记录成败。我们描述了SURE/UHSC干预措施的演变及其关键特征。